ACET - Adicet Bio gains on FDA fast track designation for ADI-001 in lupus nephritis June, 05 2024 07:45 AM Adicet Bio Inc. 2024-06-05 07:45:31 ET More on Adicet Bio Adicet Bio: Microcap With A High Risk To Reward Ratio Adicet Bio GAAP EPS of -$0.69 beats by $0.01 Seeking Alpha’s Quant Rating on Adicet Bio Historical earnings data for Adicet Bio Financial information for Adicet Bio For further details see: Adicet Bio gains on FDA fast track designation for ADI-001 in lupus nephritis